Frontage Holdings Corporation (HKG:1521)
Hong Kong · Delayed Price · Currency is HKD 1.080
+0.010 (0.93%)
Jul 10, 2026, 9:39 AM HKT
Frontage Holdings Market Cap
Frontage Holdings has a market cap or net worth of 2.17 billion as of July 9, 2026. Its market cap has decreased by -12.83% in one year.
Market Cap
2.17B
Enterprise Value
2.87B
Revenue
2.00B
Ranking
n/a
PE Ratio
41.67
Stock Price
1.08
Market Cap Chart
Since May 30, 2019, Frontage Holdings's market cap has decreased from 6.73B to 2.17B, a decrease of -67.74%. That is a compound annual growth rate of -14.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 2.17B | 7.00% |
| Dec 31, 2025 | 2.03B | -43.71% |
| Dec 31, 2024 | 3.60B | -23.57% |
| Dec 29, 2023 | 4.71B | -20.20% |
| Dec 30, 2022 | 5.91B | -27.11% |
| Dec 31, 2021 | 8.10B | -6.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioDlink International Company | 2.78B |
| Antengene Corporation | 2.66B |
| TYK Medicines | 2.62B |
| Viva Biotech Holdings | 2.56B |
| Beijing Luzhu Biotechnology | 2.53B |
| HJ Science | 2.49B |
| PegBio | 2.16B |
| AIM Vaccine | 2.06B |